Optimizing mRNA-LNP Storage Buffers for Better Vaccine Stability and Efficiency
Researchers from The University of Texas at Austin, in collaboration with Eli Lilly and Company, have discovered that optimizing storage buffers—the chemical solutions used to stabilize mRNA-lipid nanoparticles (LNPs)—can significantly … Read More